Complement 5a Receptor Antagonist

Name
Complement 5a Receptor Antagonist
Accession Number
DBCAT005653
Description

Not Available

Drugs
DrugDrug Description
AvacopanAn orally bioavailable complement 5a receptor (C5aR) antagonist for the treatment of severe anti-neutrophil cytoplasmic (auto)antibody (ANCA)-associated vasculitis.
Drugs & Drug Targets
DrugTargetType
AvacopanC5a anaphylatoxin chemotactic receptor 1target
AvacopanCytochrome P450 3A4enzyme
AvacopanP-glycoprotein 1transporter
AvacopanCytochrome P450 1A2enzyme
AvacopanCytochrome P450 2B6enzyme
AvacopanCytochrome P450 2C9enzyme